STAR*D: Lessons learned for primary care

Primary Psychiatry

Volumn 14, Issue 1, 2007, Pages 51-58

  Ziffra, Michael S ^a   Gilmer, William S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; LIOTHYRONINE; LITHIUM; MIRTAZAPINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; VENLAFAXINE;

COGNITIVE THERAPY; COMORBIDITY; HUMAN; MAJOR DEPRESSION; PRIMARY MEDICAL CARE; RELAPSE; REMISSION; REVIEW; TREATMENT OUTCOME;

EID: 33846377265     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Oxman TE, Dietrich AJ, Schulberg HC. The depression care manager and mental health specialist as collaborators within primary care. Am J Geriatr Psychiatry. 2003;11(5):507-516.
2. Wang PS, Demler O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92(1):92-98.
3. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry, 2005;62(6):629-640.
4. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58(1):55-61.
5. Hirschfeld MR, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277(4):333-340.
6. Ziffra MS, Friedman RS. To screen or not to screen: is that the question? Improving the outcomes of depression in primary care. J Clin Outcomes Manage. 2006;13(10):562-571.
7. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced treatment alternative to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119-142.
8. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am. 2003;26(2):457-494.
9. Gaynes BN, Davis L, Rush AJ, Trivedi M, Fava M, Wisniewski SR. The aims and design of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Primary Psychiatry. 2005;12(2):36-41.
10. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
11. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-1917.
12. Gaynes BN, Rush AJ, Trivedi M, et al. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. Gen Hosp Psychiatry. 2005;27(2):87-96.
13. Yates WR, Mitchell J, Rush AJ, et al. Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry. 2004;26(6):421-429.
14. Rush AJ, Zimmerman M, Wisniewski SR, et al. Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J Affective Disord. 2005;87(1):43-55.
15. Gilmer WS, Trivedi MH, Rush AJ, et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-0 project. Acta Psychiatr Scand. 2005;112(6):425-433.
16. Hollon SD, Shelton RC, Wisniewski S, et al. Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. J Psychiatr Res. 2006;40(1):59-69.
17. Rush AJ, Trivedi MH, Wisniewski, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354(12):1231-1242.
18. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243- 1252.
19. Fava M, Rush AJ, Wisniewski SR, et al. A comparison or mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry. 2006;163(7):1161-1172.
20. Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006;163(9):1519-1530.
21. McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry. 2006;163(9):1531- 1541.
22. IDS/QIDS. Available at: www.ids-qids.org. Accessed December 18, 2006.
23. Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry. 2005;59(6):493-501.
24. Stettin GD, Yao J, Verbrugge RR, Aubert RE. Frequency of follow-up care for adult and pediatric patients during initiation of antidepressant therapy. Am J Manag Care. 2006;12(8):453-461.
25. Simon GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry. 2001;58(4):395-401.
26. Lin EH, Katon WJ, Simon GE, et al. Low-intensity treatment of depression in primary care: is it problematic? Gen Hosp Psychiatry. 2000;22(2):78-83.
27. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry. 1993;54(11):405-418.
28. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 1998;52(10):850-856.
29. Depression and Bipolar Support Alliance. Available at: www.dbsalliance.org. Accessed December 18, 2006.
30. Depression and Bipolar Support Alliance. DBSA Support Groups: An Important Step on the Road to Wellness. Chicago IL; 2002. Available at: www.dbsalliance.org/site/PageServer?pagename=about_publications. Accessed December 18, 2006.
31. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342(20):1462-1470.
32. McMahon FJ, Buervenich S, Charney D, et al. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet. 2006;78(5):804-814.
33. STAR*D. Available at: www.star-d.org. Accessed December 18, 2006.
34. National Institute of Mental Health. Available at: www.nimh.nih.gov. Accessed December 18, 2006.